Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sheng Bai Oral Liquid for Chemotherapy-Induced Neutropenia in NSCLC
NCT03413358Phase 4Unknown
- Start
- Jan 2018
- Primary completion
- Oct 2019
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of Shengbai oral liquid in neutropenia. Status: unknown.
02
Drugs
Shengbai oral liquid
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT03413358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03413358.